Survodutide vs Retatrutide | Research Comparison | QSC

Survodutide vs Retatrutide

Mechanism, clinical data, and research applications

Shop Both at QSC →

Factor Survodutide Retatrutide
Receptors GLP-1R + GCGR GLP-1R+GIPR+GCGR
Best Trial Result Phase 2 NASH data −24.2% (48wks)
At QSC ✓ In Stock ✓ In Stock
Analysis: Both have GCGR component; retatrutide adds GIPR. Survodutide has stronger GCGR bias (hepatic).
Research Use Only.
Peptides
Orals
Oils
Search
Contact